グリア成長因子2の所望の血漿レベルを達成するための方法

Title:

グリア成長因子2の所望の血漿レベルを達成するための方法

Document Type and Number:

Japanese Patent JP2011513310

Kind Code:

A

Abstract:

The present invention relates to administering glial growth factor 2 (GGF2) to a patient in need thereof, to achieve serum levels of GGF2 within a desired therapeutic window determined based on the disease or disorder afflicting the patient. In a particular embodiment, the patient is suffering from a disease or disorder associated with reduced levels of myelination and the GGF2 is administered to promote myelination in the patient.

More Like This:

WO/2020/019813	LONG-ACTING OXYNTOMODULIN HYBRID PEPTIDE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
JPH08228777	FUSED GENE FOR PRODUCING HYBRID PROTEIN
JP2023078143	COMPOSITIONS IN FORM OF INJECTABLE AQUEOUS SOLUTION COMPRISING AT LEAST HUMAN INSULIN A21G AND PRANDIAL ACTION GLUCAGON SUPPRESSOR

Inventors:

Kim hee sung
Cagiano Anthony Oh.

Application Number:

JP2010548749A

Publication Date:

April 28, 2011

Filing Date:

March 02, 2009

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Accordor Therapeutics, Inc.

International Classes:

A61K38/22; A61P9/04; A61P9/06; A61P9/10; A61P25/00; A61P25/02; A61P27/02; A61P39/02; A61P43/00

Domestic Patent References:

JP2007516229A

2007-06-21

Foreign References:

WO1994004560A1

1994-03-03

Other References:

JPN6013043413; Ｔ．Ｏｇａｔａ，　ｅｔ　ａｌ．，　Ｔｈｅ　Ｊｏｕｒｎａｌ　ｏｆ　Ｎｅｕｒｏｓｃｉｅｎｃｅ，　２００４，　２４（３０），　ｐｐ６７２４-６７３２
JPN6013043410; Ｐ．Ｍａｕｒｅｌ，　ｅｔ　ａｌ．，　Ｔｈｅ　Ｊｏｕｒｎａｌ　ｏｆ　Ｎｅｕｒｏｓｃｉｅｎｃｅ，　２０００，　２０（１２），　ｐｐ４６３５-４６４５

Attorney, Agent or Firm:

Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto

Previous Patent: JP2011513309

Next Patent: エピクロロヒドリンの製造及び精製用プロセス及び装置